If we want our medicine to be the to-go industry standards, we need to make sure that it is accessible everywhere in the world. But this is also something that needs to be planned from the very beginning. We need to incorporate the global perspective from the very beginning, and not later on in the game, to be able to roll out the medicine successfully. But how exactly do we do this and what do we need to change?

In this presentation you will learn:

• How to develop a molecule with the global footprint in mind?
• How to deal with various end-points?
• How to secure early access and early approval in diverse countries from the start?
• How to raise awareness and design the commercial strategy accordingly?